#None #Rosen Law Firm #Securities Class Action #GeneDx Holdings Corp.

Rosen Law Firm Encourages Action from GeneDx Investors

The Rosen Law Firm, recognized as a leading global firm for investor rights, is actively investigating potential securities claims for investors of GeneDx Holdings Corp. (NASDAQ: WGS). This investigation arises amidst serious allegations suggesting that GeneDx may have misled the investing public through materially incorrect business information.

Overview of the Situation

On February 5, 2025, Grizzly Research published a damning report claiming that GeneDx was allegedly engaged in widespread fraud. The report, titled "Insiders Attest that GeneDx (Nasdaq WGS) Is Actively Committing Widespread Fraud," pointed out that the firm's growth was largely fabricated, contingent upon illegal activities that exploited Medicaid and Medicare systems to inflate revenue artificially.

As a result, GeneDx’s stock experienced a notable drop of 6.7% on the same day the report was issued, raising alarm among investors.

What This Means for Investors

If you have invested in GeneDx securities, you might be entitled to compensation without any upfront fees or expenses through a contingency fee arrangement. The Rosen Law Firm is preparing a class action to recover losses incurred by investors due to the alleged fraudulent practices of GeneDx. This move reflects the firm’s commitment to ensuring that investors are adequately represented and compensated for their losses.

To participate in this prospective class action, investors are encouraged to visit rosenlegal.com or reach out directly to Phillip Kim, Esq. at their toll-free number (866) 767-3653 for more details.

The Importance of Choosing the Right Counsel

Selecting a qualified legal advisor with a solid track record in securities class actions is crucial. The Rosen Law Firm encourages investors to carefully consider their representation, as some firms lack the necessary experience, resources, or recognition in handling securities class actions.

Rosen Law Firm has traditionally focused on providing diligent representation for investors, achieving significant settlements—like the numerous millions recovered for clients in past cases, including over $438 million in 2019 alone. The firm's founder, Laurence Rosen, has been acknowledged as a key figure in the realm of securities law, gaining accolades indicating their prowess in this specialized area.

Additionally, in 2020, he was honored as a Titan of Plaintiffs' Bar by Law360, and the firm has consistently ranked at the top for the number of securities class action settlements.

Follow-Up and Updates

Investors interested in the case can stay informed through the firm’s social media channels, including LinkedIn, Twitter, and Facebook. The Rosen Law Firm maintains open communication to provide updates as the investigation progresses, emphasizing the importance of keeping affected investors in the loop regarding their rights and responses to the allegations against GeneDx.

In summary, if you are a shareholder of GeneDx Holdings Corp. and believe you may have been impacted by their actions, contacting the Rosen Law Firm now may be a prudent step. Through their expertise and history of success, you can ensure that your rights as an investor are fiercely defended, and any potential losses you have suffered could be mitigated through proper legal channels.

For more information, reach out to:

• - Laurence Rosen, Esq.
• - Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Telephone: (212) 686-1060
Toll-Free: (866) 767-3653
Email: [email protected]
Website: www.rosenlegal.com